Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's revision/version metadata rather than changes to visible content.
    Difference
    0.0%
    Check dated 2026-05-17T10:22:52.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-25T18:47:34.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T13:37:50.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    - Revision tag updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T01:20:08.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T17:44:14.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing the previous v3.4.1. No study details or user interactions are affected.
    Difference
    0.0%
    Check dated 2026-02-13T13:23:27.000Z thumbnail image

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.